ArcticZymes Technologies ASA (OSTO:BIOTECO)
kr 16.48 0 (0%) Market Cap: 871.28 Mil Enterprise Value: 639.78 Mil PE Ratio: 61.64 PB Ratio: 2.77 GF Score: 80/100

Biotec Pharmacon ASA - Special Call Transcript

Dec 10, 2019 / 01:00PM GMT
Release Date Price: kr4.75
Marie Ann Roskrow
Biotec Pharmacon ASA - Chairperson

So good afternoon, ladies and gentlemen, and welcome to the Investor Update Meeting. We've basically set aside 1.5 hours for the meeting. So Jethro, who I'll introduce in a moment, will give a presentation -- and those are the slides I just handed out -- of roughly about 0.5 hour, and then that will leave us an hour, give or take, to answer your questions.

We do have to leave promptly on time because we're dashing to another meeting. So I hope you appreciate that. And I think that's plenty of time that we can have a good question-and-answer session as well.

What we'd like to focus on today? Please come in gentlemen. What we'd like to focus on in the presentation is the current situation, obviously, is what's going on at Biotec Pharmacon and I think in more detail to lay out what our plans are for the future and where we see the excitement and the growth within this company.

This year, as many of you know, because you're seasoned shareholders in this company, we've had to take some strategic and difficult decisions. And I

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot